Omicron Jolts Markets; FTSE-100 Too Rattled

Renewed worries over whether the heavily mutated Omicron variant's surge can be managed with the existing vaccines infected global markets worldwide. Efficacy concerns raised by Moderna exacerbated the sentiment and FTSE 100 has dropped around 0.69 percent.